Investigative Urology - Results from #5280

Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif - Abstract November 7, 2012

Cell-free Serum DNA in patients with bladder cancer: Results of a prospective multicenter study - Abstract November 6, 2012

Epigenetic alterations in bladder cancer and their potential clinical implications - Abstract November 6, 2012

Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castrate-resistant prostate cancer - Abstract November 6, 2012

Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells - Abstract November 6, 2012

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer - Abstract November 6, 2012

Targeting androgen receptor leads to suppression of prostate cancer via induction of autophagy - Abstract November 6, 2012

IGFBP7 promoter methylation and gene expression analysis in prostate cancer - Abstract November 6, 2012

Sabutoclax, a mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer - Abstract November 5, 2012

Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements - Abstract November 5, 2012

The tumor microenvironment in prostate cancer: Elucidating molecular pathways for therapy development - Abstract November 2, 2012

CK5, CK5/6, and double-stains CK7/CK5 and p53/CK5 discriminate in situ vs invasive urothelial cancer in the prostate - Abstract November 2, 2012

14-3-3ζ, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival - Abstract November 2, 2012

Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range - Abstract November 2, 2012

Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: Proliferation in cancer cells and differentiation in noncancerous cells - Abstract November 2, 2012

Pseudolaric acid B induces caspase-dependent apoptosis and autophagic cell death in prostate cancer cells - Abstract November 2, 2012

Effects of bortezomib in sensitizing human prostate cancer cell lines to NK-mediated cytotoxicity - Abstract November 1, 2012

The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: A meta-analysis - Abstract November 1, 2012

The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells - Abstract November 1, 2012

Effectiveness of the combined evaluation of KLK3 genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis - Abstract November 1, 2012

Page 265 of 346